Destiny Pharma

 

Destiny Pharma focuses on the R&D of new antimicrobial drugs, with an emphasis on novel mechanisms of action, which seek to address antibiotic resistance. Through its extensive business network and strategic partnerships Destiny Pharma intends to globally commercialise candidates from the XF Drug platform, which are differentiated by design from traditional antibiotics.